Cuiping Fu

Ms. Cuiping Fu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
MYMinyue Yin
Minyue Yin
CXChao Xu
Chao Xu
JZJinzhou Zhu
Jinzhou Zhu
YXYuhan Xue
Yuhan Xue
YZYijia Zhou
Yijia Zhou
CFCuiping Fu
Cuiping Fu
Background: Asymptomatic COVID-19 carriers with normal chest computed tomography (CT) scans have perpetuated the ongoing pandemic of this disease. This retrospective study aimed to use automated machine learning (AutoML) to develop a prediction model based on CT characteristics for the identification of asymptomatic carriers. Methods: Asymptomatic carriers were from Yangzhou Third People’s Hospital from August 1st, 2020, to March 31st, 2021, and the control group included a healthy population from a nonepizootic area with two negative RT‒PCR results within 48 h. All CT images were preprocessed using MATLAB. Model development and validation were conducted in R with the H2O package. The models were built based on six algorithms, e.g., random forest and deep neural network (DNN), and a training set (n = 691). The models were improved by automatically adjusting hyperparameters for an internal validation set (n = 306). The performance of the obtained models was evaluated based on a dataset from Suzhou (n = 178) using the area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and F1 score. Results: A total of 1,175 images were preprocessed with high stability. Six models were developed, and the performance of the DNN model ranked first, with an AUC value of 0.898 for the test set. The sensitivity, specificity, PPV, NPV, F1 score and accuracy of the DNN model were 0.820, 0.854, 0.849, 0.826, 0.834 and 0.837, respectively. A plot of a local interpretable model-agnostic explanation demonstrated how different variables worked in identifying asymptomatic carriers. Conclusions: Our study demonstrates that AutoML models based on CT images can be used to identify asymptomatic carriers. The most promising model for clinical implementation is the DNN-algorithm-based model.

4 April 2025 in Rehabilitation Nursing Journal
Verified
Journal Article
Open access
XCXUAN CHEN
XUAN CHEN
CFCuiping Fu
Cuiping Fu
XWXiongbiao Wang
Xiongbiao Wang
MSMeng Sun
Meng Sun
JSJindong Shi
Jindong Shi
SLShanqun Li
Shanqun Li
Background: Despite promising individual benefits, the combined efficacy of Baduanjin and Tri-Ball Breath training as a home-based pulmonary rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) subjects remains unexplored. Objective: The aim of the study was to evaluate the effect of combining Baduanjin (a traditional Chinese exercise) and Tri-Ball Breath training into a home-based pulmonary rehabilitation regimen for COPD patients. Methods: A multicenter randomized controlled trial was conducted, enrolling 240 moderate COPD patients from 10 hospitals. Participants were randomly assigned to four groups: Baduanjin group, Tri-Ball Breath training group, Combination training group, and control group. The intervention lasted 12 weeks. Data were collected at baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks post-intervention. Results: After 12 weeks, the 6-Minute Walk Distance (6MWD) significantly improved in the Baduanjin group and the Tri-Ball Breath training group (p <0 .05), with the most significant improvement observed in the Combination training group (p <0 .01) compared to the control group. FEV1% increased in the Baduanjin group and the Tri-Ball Breath training group (p <0 .05) and markedly improved in the Combination training group (p <0 .01). No significant differences were observed in the COPD Assessment Test (CAT), the Modified British Medical Research Council Scale (mMRC), or the Traditional Chinese Medicine symptom scores at 4-week and 8-week. The mMRC scores improved significantly in the Baduanjin group and the Combination training group at 24-week (p <0 .05). The vital signs of all participants were stable from the baseline, and no statistic difference was observed among the four groups at all visits. Conclusion: Our findings underscore the significance of incorporating Baduanjin and respiratory muscle training into the long-term management of COPD patients. By fostering continuous improvements in pulmonary function (FEV1%) and exercise capacity (6MWD), these interventions may help to mitigate disease progression and enhance patients' quality of life.

4 May 2024 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
RQRuiqi Qian
Ruiqi Qian
LYLingyi Yang
Lingyi Yang
XSXurui Shen
Xurui Shen
CCCheng Chen
Cheng Chen
JHJianan Huang
Jianan Huang
CFCuiping Fu
Cuiping Fu
Objective. Our study aimed to develop a predictive model for evaluating the clinical response of omalizumab treatment in moderate-to-severe asthma patients. Methods. This single-center, prospective study collected patients who meet the diagnostic criteria for moderate-to-severe bronchial asthma set by the National Asthma Prevention and Treatment Group in 2016 in the first hospital affiliated with Soochow University. Patients recruited were treated with omalizumab once per four weeks; at the beginning of each injection, blood eosinophils and the level of total serum IgE (IU/mL) were tested. After four injections of omalizumab, asthma control test (ACT), the 15-item Mini Asthma Quality of Life Questionnaire (MiniAQLQ), global treatment effectiveness (GETE), and lung function of all patients were evaluated in the 16th week. We used the selection operator method to build a logistic model and evaluated the clinical response of omalizumab in these patients. Results. This study included 108 moderate-to-severe patients (aged 39.86±14.59years). Eighty-nine patients finished treatment for 16weeks, and 74 patients (83.1) had an excellent or good response. The serum level of total IgE increased significantly after injection of omalizumab, while blood eosinophils count decreased significantly from baseline. Using the GETE as a clinical outcome, several clinical variables were significant predictors of clinical response. The corrected AUC and Brier scores were 0.872 and 0.111, which showed good discrimination. Significant variables included age, weight, family allergic history, acute exacerbations, the ratio of total serum IgE level at the 4th week to the baseline level, forced expiratory volume in one second/forced vital capacity (FEV1/FVC), and commodities of rhinitis. Using the improvement in maximal expiratory flow 25 of the measured value to the predicted value (MEF25pre) as clinical outcome, the significant variables included weight, duration of asthma, use of oral corticosteroids (OCS), total serum IgE level at the 4th week, and history of rhinitis. Its corrected AUC and Brier scores were 0.674 and 0.225 after internal validation. Conclusion. Omalizumab treatment remarkably improved asthma control and pulmonary function in Chinese patients with moderate-to-severe asthma. The response prediction model we developed provides convenient approaches to help identify better clinical response patients to omalizumab treatment.

23 December 2020 in Research Square
Verified
Preprint
Open access
PDF file
JGJie Gu
Jie Gu
TZTingting Zuo
Tingting Zuo
QZQingqing Zhu
Qingqing Zhu
HCHui Chen
Hui Chen
YCYanbin Chen
Yanbin Chen
CFCuiping Fu
Cuiping Fu
Objective: Balanced fluid with no critical increase of chloride in serum was recommended in clinic. Whether hyperchloremia could make a difference for intensive care unit (ICU) patients with a higher acute kidney injury (AKI) occurrence remains controversial.Methods: The Medical Information Mart for Intensive Care III (MIMIC-III) database was searched to identify patients hyperchloremia or non-hyperchloremia, and relationship between level of chloride and AKI incidence was analyzed using the univariate and multivariate logistic regression. Patients were divided into four disease subgroups based on the diagnosis at admission: cardiac, cerebral, gastrointestinal, respiratory. The association between maximum chloride (chloride_max) and incidence of AKI in each subgroup was evaluated using the Lowess Smoothing technique. Receiver operating characteristic curves were applied to analyze the diagnostic value of hyperchloremia (chloride_max>110mmol/L) in these four subgroup patients.Results: A total of 34,617 patients were included in our study, of which 12667 patients (36.6%) was diagnosed with hyperchloremia. The risk of incidence of AKI was increased in the hyperchloremia group. As the higher level of hyperchlorimia, the bigger adjusted odds ratio (OR) presented in terms of AKI, with the OR increasing from 1.13 (95%CI 1.06-1.21; P<0.001) to 4.09 (95%CI 3.04-5.52; P<0.001). Normal level of chloride (95-110mmol/L) was associated with the lower incidence of AKI rate compared to the hypochloremia (110mmol/L) in any subgroup of cerebral, cardiac, respiratory and gastrointestinal disease. The diagnostic performance was good for cerebral disease (AUC=0.617), cardiac disease (AUC=0.636), respiratory disease (AUC=0.623) and gastrointestinal disease (AUC=0.633). The optimal cut-off value in terms of chloride_max for diagnosing AKI was 116mmol/L for the subgroup of cerebral, respiratory and gastrointestinal diseases, and 115 mmol/L for cardiac patients.Conclusion: Hyperchloremia was associated with increased risk adjusted AKI incidence among critical ill patients. For ICU patients with cerebral, gastrointestinal and respiratory admission diagnose, the predictive threshold was at 116mmoL/L, and cardiac diagnose was at 115 mmol/L.